Background/Objectives: Pancreatic ductal adenocarcinoma (PDA) with cystic change is classified into several types according to the features of the cysts; however, those tumors do not constitute a uniform group, and the classification is controversial.
Introduction
Ductal adenocarcinoma with a solid growth pattern is the major type of pancreatic tumor, 1, 2 characterized by irregular glandular proliferation of tumor cells on a fibrous stroma background. Cystic tumors of the pancreas are relatively rare in comparison with solid tumors; however, they are being diagnosed increasingly often due to improvements in abdominal imaging modalities such as high-resolution computed tomography (CT) and magnetic resonance imaging (MRI). 3 The commonest cystic pancreatic tumors are intraductal papillary-mucinous neoplasm (IPMN), serous cystic neoplasm (SCN), mucinous cystic neoplasm (MCN) and solid pseudopapillary neoplasm (SPN). [2] [3] [4] [5] [6] We recently analyzed 200 cases of pancreatic ductal adenocarcinoma (PDA) that were treated surgically at a single institution, and extracted the clinical and histopathological features of 7 cases that showed an unusual multiple large cystic (MLC) structures.
PDAs with MLC lesions did not wholly fulfill the criteria proposed by Kosmahl et al. 2 for classification of cystic PDAs. Since, like conventional PDAs, MLC-type PDA has a very poor prognosis, diagnostic pathologists should bear in mind that MLC-type PDA can form cystic lesions similar to those of IPMN and MCN. 5 
Materials and methods

Patient selection
A total of 200 PDAs, which were surgically resected at the Department of Surgical Oncology, Hokkaido University Hospital, between December 2000 and July 2011, and had been pathologically confirmed, were examined for the present analysis. Among them, 22 (11%) showed cystic lesions. Fifteen out of these 22 cases were classifiable as cystic pancreatic ductal adenocarcinomas on the basis of the criteria of Kosmahl et al. 2 The remaining 7 cases were PDAs with a MLC structure that were not classifiable by those criteria. Here we describe the clinicopathological and immunohistochemical features of these MLC-type PDAs. All of the tumors had been diagnosed on the basis of the WHO classification. The clinical characteristics and follow-up data for the patients were obtained from the medical records and, in some cases, from the physicians in charge.
Validation test
An additional 5 cases (Cases A to E) of non-cystic (conventional) PDAs archived from our files were used to validate the immunohistochemical staining in our hospital. 6 
Histopathological examination
All specimens were fixed with 10% neutral buffered formalin, and embedded in paraffin. Deparaffinized sections were stained with hematoxylin-eosin and examined by light microscopy.
Immunohistochemistry
Representative serial sections were prepared from formalin-fixed, paraffin-embedded (FFPE) tissue blocks. Immunohistochemistry was performed using the EnVision+ system (Dako Cytomation, Glostrup, Denmark). Details of the primary antibodies used are listed in Table 1 . Negative and positive controls were included on each of the tested glass slides.
KRAS mutation analysis
In the 7 PDAs showing prominent MLC structures, we investigated the presence of mutations in codon 12 of the KRAS gene. The method used has been described previously. Briefly, it is a high-throughput screening system utilizing Luminex (xMAP) technology (the fluorescent bead-based multiplex analyte profiling method), in combination with the polymerase chain reaction-reverse sequence-specific 7 oligonucleotide method using FFPE tissues, giving results comparable to those obtained by direct sequencing. 7
Postoperative survival
Follow-up information after surgical resection was available for all 22 patients diagnosed as having PDA with a cystic structure. Response to chemotherapy was evaluated by the criteria based on the Response Evaluation Criteria in Solid Tumors (RECIST) version 1.0. 8 The mean follow-up period was 23 months (range, 4-60 months). We compared the postoperative survival of patients with cystic PDA with and without MLC structures.
Statistical analysis
Statistical analyses were performed using StatFlex 6.0 (Artech Co. Ltd., Japan).
Survival curves were calculated by the Kaplan-Meier method, and differences in survival were evaluated using the log-rank test. Statistical significance was set at p<0.05.
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Results
Clinical and radiographic features
The main clinicopathologic features are summarized in Table 2 . Of the 7 studied patients, 5 were men and 2 were women, and their mean age was 66 years (range, 51 to 79 years). Four patients were asymptomatic, and their pancreatic tumors had been Recurrent tumors were observed in the peritoneum in 2 cases (cases 3 and 5), and the lymph nodes around the abdominal aorta (case 1) and lung (case 4) in the remaining 2 cases, respectively.
Macroscopic features
All of the MLC-type PDAs had similar characteristic macroscopic features: a mixture of various-sized rounded large cysts distributed at the periphery of solid lesions and intratumoral small cysts ( Figure 2 ). Most of these tumors contained multiple (more than 5) large cystic structures. The maximal cyst diameter was 2.0 cm or more in all patients (range, 2.0 to 5.0 cm, mean 3.7 cm). The average tumor size including the MLC structure was 6.0 cm (range, 4.0 to 8.0 cm).
Histologic features
The cysts in the neoplasms were lined by cuboidal to columnar epithelial cells ( Figure 3 ) and formed a single cell layer, although occasional papillary projections and Roman-bridge-like structures were partially evident. The cytoplasm was usually eosinophilic, and the nuclei were irregularly round to oval. The mitotic count in the high-grade dysplastic epithelial cells lining the cyst wall varied from case to case (range, 0 to 3 per 10 high-power fields, Table 2 ). Mucin secretion was not evident. Cyst-lining epithelial cells tended to show high-grade dysplasia in closer proximity to the tumor, whereas low-grade dysplasia and partially normal epithelium were predominant in the periphery ( Figure 3C -D). The cystic structures were embedded in a paucicellular fibrotic and/or desmoplastic stroma, which did not resemble an ovarian-like stroma.
Most of the tumors were classified as moderately differentiated tubular adenocarcinoma as they contained a mixture of medium-sized duct-like structures, small tubular glands of variable size and shape, and partially cribriform glands. Numerous angular or irregular neoplastic duct-like glands were present within the tumor, forming a honeycomb-like pattern ( Figure 3A-B ).
Immunohistochemical features
The immunohistochemical profiles are summarized in Table 4 and Figure 4 .
Immunohistochemically, all of the MLC-type PDAs were positive for maspin and CEA in the both cells of the cyst lining and intervening smaller tubular glands in the solid area. In some cases, these components were stained weakly for MUC5AC. The 
KRAS mutation analysis
Analysis of the KRAS gene demonstrated mutation involving the codon 12 in 6 out of 7 cases (86%, Table 2 ).
Postoperative outcome
The overall survival (OS) rate for the 7 MLC-type PDAs patients was 80% at 1 year, 53% at 3 years after surgery. On the other hand, the OS rate for the 15 other cystic-type PDAs patients was 76% at 1 year, 38% at 3 years after surgery.
A postoperative follow-up study of the 22 patients with PDAs with cystic structures revealed that postoperative outcome was not affected by the presence of a MLC
Discussion
Most pancreatic neoplasms have a solid growth pattern and are classified as ductal adenocarcinoma. 1, 2 Cystic neoplasms of the pancreas are relatively uncommon, but have increasingly attracted a great deal of attention recently because they encompass a wide spectrum of pathologic entities that vary considerably in morphology, clinical behavior, and pathogenesis. [2] [3] [4] [5] [6] As a result of recent improvements in abdominal imaging modalities, an increasing number of neoplastic cystic lesions of the pancreas are being identified in patients who are clinically asymptomatic. 3 The pathological classification of these various types of cystic pancreatic neoplasms is still evolving, but the most common types include IPMN, SCN, MCN, and SPN. [2] [3] [4] [5] [6] Rarer cystic neoplasms include acinar cell cystadenocarcinoma, 9 acinar cell cystadenoma, 10 cystic neuroendocrine tumor 11 and cystic mesenchymal tumor. 12 However, it should always be borne in mind that the differential diagnoses of cystic neoplasms of the pancreas should also include PDA with cystic change.
Recently, a morphological variant of PDA forming large ductal elements, "large duct type" ductal adenocarcinoma, has been reported. 13 These tumors may have microcystic and papillary growth patterns that closely mimic those of non-invasive cystic and papillary pancreatic tumors such as IPMN, MCN, and the ducts involved in PanIN. 13 Based on the descriptions of those tumors, we consider that the features of the large ductal elements they contained were similar to those seen in the large cysts in our present series of 7 MLC lesions, although the cysts in the latter had a much larger average diameter. Our studied cases also showed microcystic changes within the solid area, which have also been reported as a characteristic feature of cystic PDAs.
Kosmahl et al. 2 In the present study, we examined the clinicopathologic and immunohistochemical features of 7 PDAs with a MLC structure that did not wholly fulfill the above criteria of were apparently larger than those of the large-gland type, and were mostly MUC series-negative, whereas the large-gland type were generally positive, especially for MUC1, MUC5AC, and MUC6. Moreover, the cyst-lining epithelial cells in the MLC type, whose atypia varied from none to high-grade dysplasia, were also different from those of the large-gland type, which consists of wholly neoplastic cells and never contains normal epithelial cells.
Other entities that have to be considered in the differential diagnosis of MLC include According to the results of KRAS mutation analysis, the MLC-type PDAs appeared to have a common biology with similar molecular alterations to conventional ductal adenocarcinomas. On the other hand, according to the prognostic data of MLC-type and other cystic-type PDAs, clinical behavior of PDAs with cystic structures appears to be better than that of non-cystic conventional type PDAs. 20 Possibly, expression of the tumor suppressor genes coded protein such as SMAD4/DPC4 might be also preserved in PDAs with cystic structures, as was reported in most noninvasive IPMNs (cystic 20 neoplasms with low malignant potential). 1, 21 The precise mechanism responsible for the development of MLC is still unclear. As a potential explanation for this unique lesion, we hypothesize that it represents a PDA with a mixture of neoplastic glandular ectasia and retention cysts. The wide spectrum of atypia shown by the epithelial cells of the cyst wall of MLC-type PDA, ranging from none to high-grade dysplasia, might represent displacement of the normal epithelia of retention cysts by neoplastic cells. The epithelial cells of these cysts tended to show a higher grade of dysplasia in close proximity to the solid tumor, whereas in the periphery, lower-grade dysplasia and partially no atypia were evident. Alternatively, de novo PanIN occurring in the cyst-lining cells could also be considered, since PanIN occurring in the branch ducts has been widely recognized as the precursor lesion of PDA. This hypothesis could also explain why the MLC lesions lacked expression of MUC1 and MUC2 protein, as is the case for retention cysts. 2 Moreover, there was no significant difference in either overall or disease-free survival between patients with MLC-type PDAs and those with other cystic PDAs. However, the size of the retention cysts and large gland-type cysts rarely exceeds 2.0 cm, 2 and the large cyst size (mean, 3.7 cm) of the MLC type is thus a distinctive characteristic, suggesting that the MLC type could represent a novel form of cystic PDA. 21 In general, when encountering any cystic neoplasm of the pancreas with MLC structures using preoperative radiographic imaging, branch duct-type IPMNs or MCNs, which are usually slow-growing and show lower malignant potential, tend to be considered first in the differential diagnosis. However, it should be borne in mind that PDAs, which are associated with very poor survival and mortality rates, can form cystic lesions similar to those of IPMNs and MCNs, which are associated with better prognosis.
In summary, we have described a series of cystic PDAs, termed the "MLC" type, that show distinctive and previously unreported morphologic and immunohistochemical features. These findings suggest that MLC lesions can probably be considered as PDAs with a mixture of neoplastic glandular ectasia and retention cysts, but that MLC-type PDA might also represent a new entity of cystic PDA exhibiting extraordinarily large cysts.
Disclosure/conflict of interest statement
None of the authors have any conflicts of interest to disclose. 
Titles and legends to figures
Figure 2
Macroscopic images of the cut surface of the surgically resected specimen from case 6.
The tumor appears as a firm, tan-white solid mass with intratumoral small cysts (arrows), and multiple large cystic structures at the periphery. 
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